In the absence of medical contraindications to surgery, resection is the mainstay of treatment
for localised oesophageal cancer. Advancements in preoperative staging and imaging …

Background Over the past 50 years there has been a remarkable change in the
epidemiology of esophageal cancer. Previously rare, adenocarcinoma of the esophagus …

BACKGROUND In patients with locoregional carcinoma of the esophagus or
esophagogastric junction who underwent preoperative chemoradiation, it is unclear whether …

Objective To document the clinicopathologic characteristics and survival of patients
undergoing esophagectomy for squamous carcinoma of the thoracic esophagus, and to …

BACKGROUND Despite increasingly radical surgery for esophageal carcinoma, a large
number of patients still experience recurrent disease soon after operation. The current study …

From the epidemiologic and therapeutic point of view, tumours of the gastroesophageal
junction should be classified either as adenocarcinoma of the distal esophagus (Type I), true …

Results: The rates of lymph-node metastasis were 0% for the 16 mucosal carcinomas and
45% for the 44 submucosal carcinomas (P< 0.01). There were no significant differences in …

Objective To document what can be accomplished with surgical resection done according to
the classical principles of surgical oncology. Methods One hundred consecutive patients …

Objective To assess the extent of disease in patients with pT1 esophageal adenocarcinoma
and to evaluate the feasibility and outcomes of a limited surgical approach. Summary …

Background A multicentre randomized study of surgical treatment of gastric cancer has
shown increased mortality and morbidity rates in patients having D2 resection. The aim of …